Because the Toronto cohort is the first population to report a significant association between PTPN22 and PsA and contradicts previous larger studies in psoriasis [5,6], this result should be interpreted with caution until it is independently validated in another PsA population. This evidence concerns the gene PTPN22 and psoriasis.